Tue, May 24, 2022

Salveen Richter Maintained (ADPT) at Hold with Decreased Target to $10 on, May 24th, 2022

Salveen Richter of Goldman Sachs, Maintained "Adaptive Biotechnologies Corporation" (ADPT) at Hold with Decreased Target from $14 to $10 on, May 24th, 2022.

Salveen has made no other calls on ADPT in the last 4 months.



There are 2 other peers that have a rating on ADPT. Out of the 2 peers that are also analyzing ADPT, 1 agrees with Salveen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tejas Savant of "Morgan Stanley" Maintained at Hold with Decreased Target to $18 on, Friday, May 6th, 2022


This is the rating of the analyst that currently disagrees with Salveen


  • Mark Massaro of "BTIG" Maintained at Strong Buy with Decreased Target to $30 on, Wednesday, February 16th, 2022